Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis
Authors
Keywords
-
Journal
ONCOGENE
Volume 37, Issue 11, Pages 1430-1444
Publisher
Springer Nature
Online
2018-01-08
DOI
10.1038/s41388-017-0036-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of signaling between human CXCR4 and zebrafish ligands by the small molecule IT1t impairs the formation of triple-negative breast cancer early metastases in a zebrafish xenograft model
- (2016) Claudia Tulotta et al. Disease Models & Mechanisms
- CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients
- (2016) S Lefort et al. ONCOGENE
- Over-Expression of POU Class 1 Homeobox 1 Transcription Factor (Pit-1) Predicts Poor Prognosis for Breast Cancer Patients
- (2016) Zhongcheng Gao et al. MEDICAL SCIENCE MONITOR
- Molecular Pathways: Targeting the CXCR4-CXCL12 Axis--Untapped Potential in the Tumor Microenvironment
- (2015) S. Scala CLINICAL CANCER RESEARCH
- CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks
- (2015) F Guo et al. ONCOGENE
- A phenotype from tumor stroma based on the expression of metalloproteases and their inhibitors, associated with prognosis in breast cancer
- (2015) Noemí Eiró et al. OncoImmunology
- Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases
- (2013) M. Gil et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A review on CXCR4/CXCL12 axis in oncology: No place to hide
- (2012) Urszula M. Domanska et al. EUROPEAN JOURNAL OF CANCER
- Tumor Metastasis: Molecular Insights and Evolving Paradigms
- (2011) Scott Valastyan et al. CELL
- A Computational Tool for Quantitative Analysis of Vascular Networks
- (2011) Enrique Zudaire et al. PLoS One
- CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model
- (2010) Saima Hassan et al. INTERNATIONAL JOURNAL OF CANCER
- Deregulation of the Pit-1 transcription factor in human breast cancer cells promotes tumor growth and metastasis
- (2010) Isabel Ben-Batalla et al. JOURNAL OF CLINICAL INVESTIGATION
- Chemokines and chemokine receptors: new insights into cancer-related inflammation
- (2010) Gwendal Lazennec et al. TRENDS IN MOLECULAR MEDICINE
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
- (2009) Balazs Györffy et al. BREAST CANCER RESEARCH AND TREATMENT
- Cxcl12a–Cxcr4b signaling is important for proper development of the forebrain GnRH system in zebrafish
- (2009) Ori Palevitch et al. GENERAL AND COMPARATIVE ENDOCRINOLOGY
- CXCL12/CXCR4 signalling in neuronal cell migration
- (2008) Marie-Catherine Tiveron et al. CURRENT OPINION IN NEUROBIOLOGY
- A CXCR4 Antagonist CTCE-9908 Inhibits Primary Tumor Growth and Metastasis of Breast Cancer
- (2008) Eugene H. Huang et al. JOURNAL OF SURGICAL RESEARCH
- Direct inhibition of the DNA-binding activity of POU transcription factors Pit-1 and Brn-3 by selective binding of a phenyl-furan-benzimidazole dication
- (2008) Paul Peixoto et al. NUCLEIC ACIDS RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started